Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cypress Pharmaceuticals
Madison, Mississippi, United Statescypresspharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cypress Pharmaceuticals was a specialty pharmaceutical company based in Madison, Mississippi, that focused on the development and commercialization of generic and branded prescription products. The company's portfolio primarily targeted therapeutic areas such as cough and cold, nutritional supplements, and pain management. In 2013, Cypress and its subsidiary Hawthorn Pharmaceuticals were acquired by Pernix Therapeutics for approximately $101 million. Following the acquisition, its operations were integrated into Pernix, which later faced financial restructuring and asset sales.
- Therapeutic areas
- NeurologyPulmonologyInfectious DiseasesMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Cypress Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cypress Pharmaceuticals.